TSW
ETON icon

Thompson Siegel & Walmsley’s Eton Pharmaceutcials ETON Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
297,232
-108,857
-27% -$3.19M 0.19% 132
2026
Q1 		$10M Sell
406,089
-2,452
-0.6% -$42.9K 0.18% 129
2025
Q4 		$6.91M Sell
408,541
-10,025
-2% -$176K 0.12% 184
2025
Q3 		$9.1M Buy
418,566
+37,301
+10% +$619K 0.15% 139
2025
Q2 		$5.43M Buy
381,265
+191,402
+101% +$3.03M 0.09% 203
2025
Q1 		$2.46M Buy
189,863
+61,824
+48% +$934K 0.04% 237
2024
Q4 		$1.71M Buy
128,039
+13,009
+11% +$132K 0.03% 257
2024
Q3 		$690K Sell
115,030
-12,694
-10% -$53.7K 0.01% 310
2024
Q2 		$420K Buy
+127,724
New +$447K 0.01% 310

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Thompson Siegel & Walmsley's ETON Position: Q2 2026 in Review

Thompson Siegel & Walmsley reduced its Eton Pharmaceutcials (ETON) stake by 27% in Q2 2026, selling an estimated $3.19M and leaving 297,232 shares worth $10.8M. The position accounts for 0.19% of the portfolio, ranked #132.

Thompson Siegel & Walmsley first reported a position in ETON in Q2 2024 and has held it in 9 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Thompson Siegel & Walmsley held 297,232 shares of Eton Pharmaceutcials worth $10.8M as of Q2 2026.
  • Thompson Siegel & Walmsley sold 108,857 Eton Pharmaceutcials shares in Q2 2026, an estimated $3.19M.
  • Eton Pharmaceutcials made up 0.19% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #132 holding.
  • Thompson Siegel & Walmsley first reported a position in Eton Pharmaceutcials in Q2 2024 and has held it in 9 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.